Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Oct 21.
Published in final edited form as: Circulation. 2014 Aug 25;130(17):1466–1473. doi: 10.1161/CIRCULATIONAHA.114.012069

Comparison of Lifestyle Based to Traditional CVD Prediction in a Multiethnic Cohort of Non-Smoking Women

Nina P Paynter 1, Michael J LaMonte 2, JoAnn E Manson 1, Lisa W Martin 3, Lawrence S Phillips 4, Paul M Ridker 1, Jennifer G Robinson 5, Nancy R Cook 1
PMCID: PMC4206581  NIHMSID: NIHMS623204  PMID: 25156990

Abstract

Background

Healthy levels of lifestyle factors can reduce risk of CVD. However, except for smoking status, often considered a traditional risk factor, their effect on cardiovascular risk prediction is unclear.

Methods and Results

We used a case-cohort design of post-menopausal non-smokers in the multiethnic Women’s Health Initiative Observational Study (1587 cases and 1808 sub-cohort participants) with a median follow-up of 10 years in non-cases. Compared to non-smokers with no other healthy lifestyle factors (healthy diet, recreational physical activity, moderate alcohol use, and low adiposity), the risk of cardiovascular disease was lower for each additional factor (hazard ratio for trend 0.82; 95% CI 0.76, 0.89), with a 45% reduction in risk with all factors (95% CI 0.36, 0.84). When lifestyle factors were added to traditional risk factor models (variables from the Pooled Cohort and Reynolds risk scores), only recreational physical activity remained independently associated with risk of cardiovascular disease. The addition of detailed lifestyle measures to traditional models showed a change in the integrated discrimination improvement and continuous net reclassification improvement (p < 0.01 for both), but had little impact on more clinically relevant risk stratification measures.

Conclusions

While lifestyle factors have important effects on CVD risk factors and subsequent risk, their addition to established CVD risk models does not result in clear improvement in overall prediction.

Keywords: lifestyle, risk prediction, primary prevention, cardiovascular diseases

Introduction

Healthy lifestyle factors related to diet, physical activity, smoking, and adiposity have been shown to be associated with reduced rates of cardiovascular disease (CVD), with an 83% lower risk of CVD for those with multiple healthy factors.1 These lifestyle factors are also part of the American Heart Association’s 2020 goals for cardiovascular disease reduction, which include improving rates of nonsmoking, having a body mass index (BMI) of 18.5 to <25 kg/m2, physical activity at goal levels, and pursuit of a diet consistent with current guideline recommendations as part of achieving a 20% reduction in CVD and stroke mortality.2

However, lifestyle factors, with the exception of smoking, have not been included in current cardiovascular risk prediction models. In development of recent Framingham risk scores, baseline BMI was assessed and found to be not significantly associated with CVD risk after adjustment for other risk factors in 10-year risk models3 and weakly but significantly associated with 30 year risk.4 Similar results for BMI were seen in the development of the Pooled Cohort model.5 In the development of the Reynolds risk score, BMI, physical activity, and alcohol use were evaluated but were not found to be significantly associated with CVD risk after adjustment for traditional risk factors.6 While some individual lifestyle factors have been evaluated, the potential improvement in risk prediction from using a combination of more detailed measures of diet, physical activity, smoking and adiposity, including measures of waist circumference, has not been assessed.

In this study we examined the association of multiple healthy lifestyle factors with incident CVD in the Women’s Health Initiative Observational Study (WHI-OS), a multiethnic cohort of post-menopausal US women. We additionally examined whether lifestyle factors provide improved CVD risk performance compared to traditional risk factors, including factors used in the Pooled Cohort and Reynolds risk scores, as well as whether the combination of lifestyle and tradition risk factors improves CVD risk prediction over traditional risk factors alone.

Methods

Population Cohort

The WHI Observational Study (WHI-OS) included 93,676 post-menopausal women aged 50 to 79 at enrollment.7 Women were recruited at 40 centers throughout the US between 1993 and 1998 and followed through 2005. Additional follow up was collected through the WHI Extension Study. All participants provided informed consent using materials approved by institutional review boards at each center.

Outcome Ascertainment

Data on self-reported outcomes through 2008 were used for this analysis. All endpoints were adjudicated through standardized medical record review.8 Confirmation of MI used medical records, electrocardiogram readings, and cardiac enzyme and troponin levels. Strokes were defined as rapid onset of a persistent neurologic deficit attributed to a thrombotic or hemorrhagic stroke, lasting more than 24 hours and without evidence of other cause. Death certificate, medical records and other records, such as autopsy reports were used to classify the underlying cause of death. The primary endpoint used was major CVD, comprised of MI, stroke, and death from cardiovascular causes.

Case-cohort Design

For this study, a prospective case-cohort design was used and the project was approved by the institutional review board at Brigham and Women’s Hospital. The cases and the sub-cohort were both sampled from the 60,890 WHI-OS participants with baseline blood samples, baseline clinical risk factor information, and no baseline history of myocardial infarction, stroke, revascularization, pulmonary embolism, deep vein thrombosis, peripheral vascular disease, or cancer. Non-whites were over sampled, with all cases of major CVD included for the black (n=200), Hispanic (n=53), Asian (n=55), and other/unknown ethnicity (n=55) women. The remaining cases (n=1637) were randomly sampled from the 2370 cases among white women. The sub-cohort sampling was stratified to match case distributions of race/ethnicity and 5-year age categories.

After further exclusion for baseline history of transient ischemic attack, CVD surgery, or congestive heart failure, and missing baseline lifestyle information, there were 1738 cases and a sub-cohort of 1896 participants (including 122 who were also cases) available for analysis. The primary analysis was limited to non-smokers, which included 1587 cases and 1808 sub-cohort participants (116 who were also cases).

Biomarker Measures

For the case and sub-cohort samples, blood samples collected and stored at −70 C° at the time of study entry were sent to a central lab certified by the National Heart Lung and Blood/Centers for Disease Control and Prevention Lipid Standardization Program. Total and high-density lipoprotein (HDL) cholesterol and high-sensitivity C-reactive protein (hsCRP) were measured in all samples. Additionally, hemoglobin A1c (HbA1c) was measured in participants with baseline diabetes.

Physical Activity Measures

Physical activity was assessed by self-administered questionnaire of recreational activity types. The energy expenditure associated with each activity was calculated using reported frequency and duration multiplied by intensity in metabolic equivalents (METs) from standardized classifications.9 Weekly totals of time spent in light, moderate and vigorous physical activity were calculated for adherence to guideline recommendations.10 Additionally, energy expenditure from all physical activity was combined into a weekly total score, which has previously been found to be predictive of CVD in the WHI-OS as well as other populations.11, 12 The physical activity questions were repeated for a subset of participants and the total expenditure in METs was found to have a weighted kappa of 0.77.7

Dietary Measures

Dietary information was collected using the WHI food-frequency questionnaire.13 The Alternative Healthy Eating Index (AHEI) score14, which measures adherence to US dietary guidelines was used. This score gives a maximum of 10 points for perfect adherence for each component and proportional points for less-than-perfect adherence and has previously shown to be associated with incident CVD in the WHI-OS 15 as well as other cohorts.14 It was constructed using reported intake of vegetables (10 points for 5 servings/day), fruit (10 points for 4 serving/day), nuts and soy protein (10 points for 1 serving/day), ratio of white to red meat (10 points for a ratio of 4 or no meat), whole grains (10 points for 3 servings/day, used as a proxy for cereal fiber), trans fat (10 points for ≤ 0.05% of total energy, 0 points for ≥ 4%), ratio of polyunstaurated to saturated fat (10 points for ≥ 1, 0 points for ≤ 0.01), and multivitamin use (7.5 point for use, 2.5 points for non use). Alcohol use, which was originally included in the AHEI, was considered as a separate risk factor and divided into non-drinkers, ≤1 drink/day, and more than 1 drinks/day.16, 17 A sensitivity analysis with alcohol included in the AHEI score was also performed. Alcohol and the other dietary measures from the FFQ were compared to 4 24hr recalls and a 4-day dietary log and were found to have high reliability.18

Adiposity Measures

Weight, height, waist circumference and hip circumference were all measured at the baseline visit. Body mass index (BMI) was calculated as weight in kilograms divided by the square of the height in meters. Waist circumference (WC) was measured at the natural waist over non-binding undergarments at the end of exhalation. Previous studies in the WHI19 and others20 have suggested that the both BMI and WC are predictive for CVD.

Additional Measures

Personal and family medical history information was collected by questionnaire at study baseline including diabetes, family history of a premature MI (before age 55 in men or age 65 in women), smoking, anti-hypertensive use, and cholesterol-lowering medication use. Average number of cigarettes smoked per day and duration of smoking were used to construct total pack years. Resting blood pressure was measured at the baseline visit.7

Statistical Methods

All analysis was done in SAS 9.2 using sampling weights to account for the case-cohort design.2123 Our method of stratified sampling from the known distribution in the full WHI-OS cohort allowed us to estimate the characteristics of the full sample by reweighting using the sampling frequency. Population characteristics were estimated using survey procedures with inverse probability weights using Proc Surveymeans.24 Pearson correlations were used to allow for incorporation of sampling weight. To generate survival models of risk factors and incident major CVD, hazard ratios and baseline hazards were obtained using weighted Cox regression in Proc Phreg.25 Asymptotic variance estimates were computed using the method of Langholz and Jiao.26

Smoking, one the key modifiable lifestyle factors, is already included in traditional risk prediction models. We chose to limit our primary analysis to non-smokers to more clearly assess the impact of additional lifestyle factors, with a secondary analysis examining the results in smokers as discussed below. We also did a sensitivity analysis of our results in participants without baseline diabetes.

To avoid over fitting in our sample, we chose lifestyle and demographic factors already shown to be associated with CVD in the entire WHI-OS and predictive of CVD in other cohorts. These included BMI, WC, physical activity (measured as MET-hrs/week), and AHEI diet score. A healthy lifestyle factor score, similar to that used in other cohorts1, was created by counting the number of the following categories met: 1) non-smoker (all participants in the primary analysis); 2) BMI between 18.5 and 24.9 or WC in the bottom 2 quintiles; 3) AHEI score in top 2 quintiles; 4) 2.5 hours of moderate intensity physical activity or 75 minutes of vigorous intensity physical activity per week; and 5) alcohol consumption greater than none, but ≤1 drink per day. In further analyses, the form for individual continuous factors (AHEI diet score, physical activity, BMI and WC) was chosen by comparing discrimination as measured by the integrated discrimination improvement (IDI).27 The IDI, which is related to an R-squared, is a measure of both prediction and model fit.28 We generated the IDI from age and race adjusted predictions based on either sub-cohort quintiles, a linear term, a log transformation, or a linear and a quadratic term. The simplest form with no significant loss of prediction was used in subsequent models.

The selected lifestyle factors (BMI, WC, quintiles of physical activity, AHEI diet score, alcohol use) were then combined with age and race to generate the “Lifestyle model”. The “PC model” used the underlying risk factors from the Pooled Cohort (PC) risk score,5 including age, smoking status, history of diabetes, anti-hypertensive treatment status, systolic blood pressure, total, and HDL cholesterol in addition to race, with coefficients re-estimated in our WHI-OS population. The “RRS model” used the risk factors from the Reynolds risk score (RRS),6 including age, smoking status, family history of a premature MI, HbA1c if the participant had a history of diabetes, hsCRP, systolic blood pressure, total, and HDL cholesterol in addition to race, with coefficients re-estimated in the study population. Of note, race was not included in either the published RRS or PC scores, but was included in this analysis to take into account the multiethnic make up of the WHI-OS and to improve comparability across models. Models adding the selected lifestyle factors to the PC and RRS models were also generated.

Predictive ability was assessed continuously using change in the c-index and the integrated discrimination improvement (IDI).27, 29 Reclassification into relevant risk categories was assessed using the net reclassification improvement (NRI) using risk categories with cut points at 5% and 7.5% 10-year risk of major CVD. The continuous NRI, which does not rely on cut-points and has been shown to be consistent with measures of association, was also calculated.30, 31 Survival methods were used for all measures as well as reweighting to approximate the distribution in the overall cohort.32 Calibration was assessed graphically using deciles of predicted risk. Statistical testing of predictive ability measures was done using 1000 bootstrap samples.

Results

The distributions of lifestyle and other risk factors among non-smokers at baseline are shown in Table 1, both in the selected sample and re-weighted to approximate the population distribution. Since this analysis was limited to non-smokers, all participants had at least one healthy lifestyle factors, but only 7% of the sub cohort and 5% of cases had all 5 factors. These percentages were similar in the weighted population estimates.

Table 1.

Comparison of baseline characteristics among non-smokers in the sampled cases, sub-cohort, and weighted to the WHI-OS non-smoking population*

Sample Weighted to Population

Subcohort (n=1,808) Cases (n=1,587) Cohort (N=50,577) Cases (N=2,138)
Age (years) 69 (63, 73) 69 (64, 73) 62 (56, 68) 69 (64, 73)
Race
 White 83% 84% 86% 88%
 Black 9% 8% 6% 6%
 Other 8% 8% 8% 6%
BMI (kg/m2) 26 (23, 29) 27 (24, 31) 26 (23, 30) 27 (24, 31)
Waist circumference (cm) 83 (75, 92) 85 (77, 96) 83 (75, 92) 85 (77, 95)
Physical activity (MET-hrs/week) 11 (4, 20) 8 (3, 18) 10 (3, 20) 8 (2, 17)
AHEI score 35 (29, 42) 35 (29, 41) 35 (29, 42) 35 (29, 41)
Alcohol use
 Never 41% 45% 40% 44%
 ≤1 drink/day 47% 42% 47% 43%
 >1 drinks/day 13% 13% 13% 13%
Number of healthy lifestyle factors
 1 11% 15% 12% 15%
 2 29% 34% 27% 34%
 3 33% 29% 31% 29%
 4 20% 17% 22% 17%
 5 7% 5% 8% 6%
Anti-hypertensive medication use 26% 38% 22% 37%
Cholesterol-lowering medication 9% 10% 7% 9%
Diabetes 4% 10% 3% 10%
Family history of early MI 18% 22% 18% 22%
Systolic Blood pressure (mmHg) 128 (117, 140) 134 (122, 148) 123 (114, 135) 133 (122, 148)
Total cholesterol (mg/dL) 226 (201, 257) 225 (198, 251) 225 (201, 257) 225 (198, 251)
HDL (mg/dL) 54 (45, 66) 49 (40, 60) 55 (46, 67) 49 (40, 60)
hsCRP (mg/L) 2.3 (1.0, 4.9) 2.9 (1.3, 5.9) 2.3 (1.0, 5.1) 2.9 (1.4, 5.8)
HbA1c % (if diabetic) 6.9 (6.2, 7.7) 7.5 (6.6, 9.0) 6.9 (6.0, 7.7) 7.5 (6.6, 8.9)
*

median (25th percentile, 75th percentile) for continuous variables, percent for categorical

Using the sampling weights from the case-cohort design

The relationships of the individual lifestyle components to CVD, after adjustment for age and race, are shown in Table 2. Optimal weight had the strongest association with CVD risk (HR 0.69). Increasing numbers of healthy lifestyle components also have a relationship with CVD risk, as shown in Table 3. Compared to the reference group of 1 factor (non-smoking), the risk of CVD was lower for each additional factor (HR trend 0.82; 95% CI: 0.76, 0.89) and the presence of all 5 risk factors was associated with a 45% lower risk (HR 0.55; 95% CI: 0.36, 0.84). After adjustment for PC components or RRS components, having all 5 factors was associated with a 20% lower risk of CVD. Results for the white and black participants separately showed similar patterns (Supplemental Table 1), with a crude reduction of risk of 75% for black participants with all 5 factors and 44% for white participants (HR trend 0.85 and 0.81, respectively). Results became less stable and were attenuated in black participants after adjustment for traditional risk factors.

Table 2.

Hazard ratios and 95% confidence intervals for incident CVD by individual healthy lifestyle components* weighted to the WHI-OS non-smoking population

Weighted Percent in Subcohort Adjusted for age and race
HR (95% CI) P value
Optimal weight 58% 0.69 (0.60, 0.80) <0.001
Healthy diet 48% 0.86 (0.75, 0.98) 0.002
Recommended physical activity 34% 0.78 (0.67, 0.91) <0.001
Moderate alcohol 47% 0.83 (0.72, 0.95) <0.001
*

The healthy lifestyle components were defined as 1) non-smoker (all participants by inclusion criteria); 2) optimal weight: BMI between 18.5 and 24.9 or WC in bottom 2 quintiles; 3) healthy diet: AHEI score in top 2 quintiles; 4) adequate physical activity: ≥ 2.5 hours of moderate intensity physical activity or ≥ 75 minutes of vigorous intensity physical activity per week; and 5) Moderate alcohol: alcohol consumption greater than none, but <1 drink per day. The reference group for each component was all other participants.

Table 3.

Hazard ratios and 95% confidence intervals for incident CVD by healthy lifestyle score weighted to the WHI-OS non-smoking population*

Healthy Lifestyle Score Sample N Unadjusted Adjusted for PC components Adjusted for RRS components
1 432 Reference Reference Reference
2 1019 0.95 (0.76, 1.01) 1.04 (0.81, 1.33) 0.97 (0.76, 1.27)
3 1015 0.78 (0.58, 1.04) 0.83 (0.65, 1.07) 0.79 (0.62, 1.02)
4 604 0.57 (0.42, 0.78) 0.81 (0.62, 1.06) 0.78 (0.59, 1.02)
5 209 0.55 (0.36, 0.84) 0.80 (0.56, 1.14) 0.80 (0.56, 1.15)
Trend 0.82 (0.76, 0.89) 0.92 (0.85, 0.98) 0.92 (0.85, 0.98)
*

The healthy lifestyle score was created by counting the number of the following categories met: nonsmoker (all participants by inclusion criteria); optimal weight; healthy diet; adequate physical activity; and moderate alcohol use.

Weighted correlation coefficients between the lifestyle factors and both traditional factors and other lifestyle variables are shown in Supplemental Table 2. The strongest correlation between lifestyle and traditional factors was waist circumference and HDL cholesterol (−0.32).

Hazard ratios for CVD risk for mutually adjusted lifestyle factors are shown in Table 4. After additional adjustment for age and race, the only lifestyle factors with hazard ratios that were not statistically significant were BMI, AHEI score and alcohol use >1 drinks/day. However, after additional adjustment for PC or RRS components, only physical activity remained independently associated with risk of CVD. Hazard ratios for all variables included in each model are shown in Supplemental Table 3.

Table 4.

1 Standard Deviation Hazard ratios and 95% confidence intervals for incident CVD for mutually adjusted lifestyle factors weighted to the WHI-OS population of non-smokers

Additionally adjusted for age and race Additionally adjusted for PC components Additionally adjusted for RRS components
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
BMI 1.00 (0.89, 1.14) 0.96 0.96 (0.83, 1.11) 0.59 0.98 (0.84, 1.13) 0.74
Waist circumference 1.22 (1.08, 1.38) 0.001 1.02 (0.88, 1.19) 0.80 0.99 (0.85, 1.16) 0.90
Physical activity quartiles
 0–1.4 MET-hrs/week Reference Reference Reference
 1.5–5.5 MET-hrs/week 0.77 (0.61, 0.98) 0.03 0.72 (0.56, 0.93) 0.01 0.72 (0.56, 0.92) 0.01
 5.6–11.7 MET-hrs/week 0.71 (0.56, 0.90) 0.004 0.69 (0.53, 0.89) 0.004 0.68 (0.53, 0.88) 0.003
 11.8–21.0 MET-hrs/week 0.67 (0.52, 0.84) 0.001 0.66 (0.51, 0.86) 0.001 0.67 (0.52, 0.86) 0.002
 21.1 + MET-hrs/week 0.66 (0.52, 0.84) 0.001 0.67 (0.51, 0.87) 0.002 0.65 (0.50, 0.85) 0.002
AHEI score 0.98 (0.92, 1.07) 0.84 0.97 (0.90, 1.05) 0.50 0.98 (0.91, 1.06) 0.66
Alcohol use
 Never Reference Reference Reference
 ≤1 drink/day 0.86 (0.73, 1.00) 0.05 0.93 (0.79, 1.10) 0.40 0.92 (0.78, 1.08) 0.31
 >1 drinks/day 0.94 (0.75, 1.18) 0.61 1.12 (0.87, 1.42) 0.38 1.10 (0.85, 1.41) 0.47

Predictive values were compared for models with lifestyle factors, the PC and RRS models alone and a combined model with both lifestyle factors and the PC or RRS factors, as shown in Table 5. Calibration plots for the lifestyle alone and lifestyle plus PC and RRS models are shown in Supplemental Figure 1. The model with age, race and lifestyle factors had lower predictive ability on all measures than all of the other models (PC, PC and lifestyle, RRS, and RRS and lifestyle). However, adding the lifestyle factors to both the PC and RRS models did result in a statistically significant continuous NRI (0.09, p < 0.001 for both) and IDI (0.004, p < 0.01 for both). The categorical NRI and change in the c-statistic were small and not statistically significant for the addition of lifestyle factors to either the PC or RRS models. The reclassification tables for the PC and RRS models alone compared with the addition of lifestyle factors are shown in Supplemental Table 4. When achievement of the recommended physical activity level alone was added to the RRS and PC models, the change in the c-statistic, categorical NRI, and IDI were non-significant, but the continuous NRI was 0.14 (p = 0.001) for both models.

Table 5.

Comparisons between CVD risk predictions based on lifestyle factors, traditional factors and combined models weighted to the WHI-OS population of non-smokers

New Model New Model c-statistic Reference Model Reference Model c-statistic Change in c-statistic IDI Continuous NRI NRI
Lifestyle + PC* 0.779 PC 0.776 0.003 (0.10) 0.004 (0.006) 0.14 (<0.001) 0.01 (0.25)
Lifestyle + RRS** 0.777 RRS 0.775 0.002 (0.10) 0.004 (0.004) 0.15 (<0.001) −0.004 (0.73)
Lifestyle + PC 0.779 Lifestyle 0.743 0.035 (<0.001) 0.026 (<0.001) 0.46 (<0.001) 0.10 (<0.001)
Lifestyle + RRS 0.777 Lifestyle 0.743 0.034 (<0.001) 0.029 (<0.001) 0.41 (<0.001) 0.09 (<0.001)
PC 0.776 Lifestyle 0.743 0.033 (<0.001) 0.023 (<0.001) 0.32 (<0.001) 0.09 (<0.001)
RRS 0.775 Lifestyle 0.743 0.032 (<0.001) 0.025 (<0.001) 0.40 (<0.001) 0.09 (<0.001)

Each row provides the results for a comparison between a reference (or old) model and a new model.

*

The PC model included age, history of diabetes, anti-hypertensive treatment status, and the natural logarithms of systolic blood pressure, total, and HDL cholesterol in addition to race, with coefficients re-estimated in the study population.

**

The RRS model included age, family history of a premature MI, HbA1c if the subject had a history of diabetes, and the natural logarithms of hsCRP, systolic blood pressure, total, and HDL cholesterol in addition to race with coefficients re-estimated in the study population.

Our subgroup analysis by age at baseline of 65 years or older produced similar results to the overall study (Supplemental Table 5). Results were also similar when smoking status was included as both the lifestyle and traditional factor models and pack years were added to the lifestyle factors. Similarly to the main results, only physical activity remained significantly associated with CVD risk in all models; the highest quintile of pack years remained significant after adjustment for PC components but not RRS components. The addition of lifestyle factors including pack years to the RRS or PC models (Supplemental Table 5) resulted in statistically significant changes to the c-index, IDI and continuous NRI, though no significant changes to the categorical NRI were observed. Similar results were also seen for participants without diabetes at baseline. Using an AHEI score including alcohol consumption in the full sample generated similar results to the main analysis, showing no association with CVD risk after adjustment for traditional risk factors.

Discussion

This study examined the association between healthy lifestyle factors and CVD risk in a multi-ethnic cohort of post-menopausal US women. In this cohort, having a greater number of healthy lifestyle factors was associated with a decrease in CVD risk. We also found that the while traditional risk factors showed superior performance in predicting CVD risk to lifestyle factors alone, adding lifestyle factors does offer improvement in overall model performance, as evidenced by the improvement of the IDI and continuous NRI. However, that improvement is small in relation to CVD risk prediction based on traditional factors alone and does not have a significant effect on classification into established clinical absolute risk categories, as shown in the non-significant categorical NRI of 0.02 or less as compared to increases of closer to 0.1 for the addition of blood pressure and smoking to similar models.33

Most of the individual lifestyle factors were associated with incident CVD in the expected direction after adjustment for age and race. Increasing BMI and WC were associated with increasing CVD risk, as seen in the WHI cohort19 and in the combined results from multiple studies by the Emerging Risk Factors Collaboration.20 Physical activity, even at low levels, was associated with decreased risk of CVD as seen in the WHI cohort and similar cohorts.34 Moderate alcohol use was also associated with a decreased risk of CVD which is consistent with the findings in the full cohort and with previous reports of a U-shaped relationship.16, 17 The AHEI diet score was not associated with CVD risk in this study, despite being associated with CVD risk in the full WHI cohort15 and other studies.14 In our results this seemed to be primarily due to the correlation with physical activity, which was not adjusted for in previous studies.

Once adjusted for the traditional risk factors, many of the associations with lifestyle factors were diminished, partially due to traditional risk factors, such as diabetes and high blood pressure, being in the causal pathway from lifestyle to CVD. However, our findings are consistent with previous studies showing some increase in CVD prediction with the addition of individual lifestyle factors. Sacco and colleagues showed improvement in CVD risk prediction by adding waist circumference, alcohol consumption and physical activity to traditional risk factors.35 Improved estimation of CVD risk with the addition of physical activity to traditional risk factors has also been suggested by Arsenault and colleagues in the EPIC-Norfolk study, though they did not assess prediction performance directly.36 The NOMAS study also found an increase in the c-statistic for CVD death of 0.736 to 0.748 in women when BMI, physical activity, and psychological distress were added to more traditional risk factors, though a formal test of the improvement was not provided.37 Additionally, Faeh and colleagues found increased risk prediction when BMI was exchanged for cholesterol in the traditional risk model.38 Different measurement of lifestyle factors may also affect the results. Our measurements of physical activity are based on self-report and more accurate measures, such as accelerometer data or fitness testing, might improve prediction further, as suggested by Gupta and colleagues.39 More accurate measures of diet which are less reliant on self-report may also affect the results, though the AHEI score has been shown to be predictive in the larger cohort15 and other studies.14 Similarly, while more accurate adiposity measures may provide additional predictive value, BMI and WC remain, in combination, the suggested measures for population health40

Our study does have important limitations. Our models were not tested on an external validation sample and our estimates of predictive ability for each model may be slight overestimates. However, we did not use data-driven methods to optimize the selection of lifestyle factors for predictive ability in our study. Instead, the pre-specified lifestyle factors have been shown to be predictive of CVD in multiple cohorts, reducing the risk of overestimation of effect, and are part of current prevention guidelines. The WHI-OS does not include any men, limiting our ability to generalize from the results. However, the relationship between healthy lifestyle factors and CVD has been similar in men and women in previous studies.

Improvements in lifestyle factors, especially physical activity and adiposity, have been shown to reduce traditional cardiovascular risk factors,4143 and are thus intrinsically important to reducing overall cardiovascular risk over the long term. Observational evidence suggests that healthy lifestyles are also associated with increased overall lifespan44 and lifestyle modifications remain part of recommended clinical practice.45 However, since some of the influence of lifestyle factors is captured by measures of traditional risk factors, they do not appear to improve prediction over the traditional models. This was quantified most recently for BMI, with blood pressure, cholesterol and diabetes mediating the CVD risk associated with higher BMI,46 and the Emerging Risk Factors Collaboration finding that BMI and WC did not improve CVD risk prediction when added to traditional risk factors alone or in combination.47 Whether a risk prediction score that includes lifestyle information would be useful to patients or physicians in motivating behavior change will require further research.

Conclusions

Healthy lifestyle factors were associated with CVD risk in this multiethnic cohort of postmenopausal women. Addition of these factors to traditional risk scores, especially physical activity, improved the overall fit of the prediction models but did not improve clinically relevant risk stratification as measured by the NRI. While inclusion of lifestyle factors, especially physical activity, in risk prediction models may provide a cohesive message about the importance of a healthy lifestyle, their additional value in risk prediction remains unclear.

Supplementary Material

Clinical Perspective
Supplemental Material

Acknowledgments

We thank the Women’s Health Initiative investigators, staff, and study participants for their outstanding dedication and commitment. A full listing of Women’s Health Initiative investigators can be found at https://www.whi.org/researchers/Documents%20%20Write%20a%20Paper/WHI%20Investigator%20Long%20List.pdf.

Funding Sources: This project was supported by NHLBI BAA award contract number HHSN268200960011C and grant HL113080 from the National Heart, Lung, and Blood Institute. The Women’s Health Initiative program is funded by the National Heart, Lung, and Blood Institute, the National Institutes of Health, and the US Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-9, 32122, 42107-26, 42129-32, and 44221 as well as through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. Dr. Phillips was supported in part by FDA award RO1FD003527, VA award HSR&D IIR 07-138, NIH awards DK066204, U01 DK091958, U01 DK098246, and a Cystic Fibrosis Foundation award PHILLI12A0.

Footnotes

Conflict of Interest Disclosures: None.

References

  • 1.Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16–22. doi: 10.1056/NEJM200007063430103. [DOI] [PubMed] [Google Scholar]
  • 2.Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD on behalf of the American Heart Association Strategic Planning Task Force Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction. Circulation. 2010;121:586–613. doi: 10.1161/CIRCULATIONAHA.109.192703. [DOI] [PubMed] [Google Scholar]
  • 3.D’Agostino RB, Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care. The framingham heart study. Circulation. 2008;117:743–53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22. [DOI] [PubMed] [Google Scholar]
  • 4.Pencina MJ, D’Agostino RB, Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: The framingham heart study. Circulation. 2009;119:3078–3084. doi: 10.1161/CIRCULATIONAHA.108.816694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson J, Schwartz JS, Shero ST, Smith SC, Sorlie P, Stone NJ, Wilson PWF. 2013 acc/aha guideline on the assessment of cardiovascular risk: A report of the american college of cardiology/american heart association task force on practice guidelines. Circulation. 2014;129(25 Suppl 2):S49–73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12. [DOI] [PubMed] [Google Scholar]
  • 6.Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The reynolds risk score. JAMA. 2007;297:611–619. doi: 10.1001/jama.297.6.611. [DOI] [PubMed] [Google Scholar]
  • 7.Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The women’s health initiative observational study: Baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003;13:S107–S121. doi: 10.1016/s1047-2797(03)00047-4. [DOI] [PubMed] [Google Scholar]
  • 8.Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M, Daugherty S. Outcomes ascertainment and adjudication methods in the women’s health initiative. Ann Epidemiol. 2003;13:S122–S128. doi: 10.1016/s1047-2797(03)00048-6. [DOI] [PubMed] [Google Scholar]
  • 9.Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O’Brien WL, Bassett DR, Jr, Schmitz KH, Emplaincourt PO, Jacobs DR, Jr, Leon AS. Compendium of physical activities: An update of activity codes and met intensities. Med Sci Sports Exerc. 2000;32:S498–504. doi: 10.1097/00005768-200009001-00009. [DOI] [PubMed] [Google Scholar]
  • 10.Physical Activity Guidelines Advisory Committee. Physical activity guidelines advisory committee report, 2008. 2008 [Google Scholar]
  • 11.Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, Perri MG, Sheps DS, Pettinger MB, Siscovick DS. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 2002;347:716–725. doi: 10.1056/NEJMoa021067. [DOI] [PubMed] [Google Scholar]
  • 12.Oguma Y, Shinoda-Tagawa T. Physical activity decreases cardiovascular disease risk in women: Review and meta-analysis. Am J Prev Med. 2004;26:407–418. doi: 10.1016/j.amepre.2004.02.007. [DOI] [PubMed] [Google Scholar]
  • 13.Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the women’s health initiative food frequency questionnaire. Ann Epidemiol. 1999;9:178–187. doi: 10.1016/s1047-2797(98)00055-6. [DOI] [PubMed] [Google Scholar]
  • 14.McCullough ML, Feskanich D, Stampfer MJ, Giovannucci EL, Rimm EB, Hu FB, Spiegelman D, Hunter DJ, Colditz GA, Willett WC. Diet quality and major chronic disease risk in men and women: Moving toward improved dietary guidance. Am J Clin Nutr. 2002;76:1261–1271. doi: 10.1093/ajcn/76.6.1261. [DOI] [PubMed] [Google Scholar]
  • 15.Belin RJ, Greenland P, Allison M, Martin L, Shikany JM, Larson J, Tinker L, Howard BV, Lloyd-Jones D, Van Horn L. Diet quality and the risk of cardiovascular disease: The women’s health initiative (whi) Am J Clin Nutr. 2011;94:49–57. doi: 10.3945/ajcn.110.011221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: An updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166:2437–2445. doi: 10.1001/archinte.166.22.2437. [DOI] [PubMed] [Google Scholar]
  • 17.Djoussé L, Lee IM, Buring JE, Gaziano JM. Alcohol consumption and risk of cardiovascular disease and death in women. Circulation. 2009;120:237–244. doi: 10.1161/CIRCULATIONAHA.108.832360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the women’s health initiative food frequency questionnaire. Ann Epidemiol. 1999;9:178–187. doi: 10.1016/s1047-2797(98)00055-6. [DOI] [PubMed] [Google Scholar]
  • 19.Hartz A, He T, Rimm A. Comparison of adiposity measures as risk factors in postmenopausal women. J Clin Endocrinol Metab. 2012;97:227–233. doi: 10.1210/jc.2011-1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wormser D, Kaptoge S, Di Angelantonio E, Wood A, Pennells L, Thompson A, Sarwar N, Kizer J, Lawlor D, Nordestgaard B. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. Lancet. 2011;377:1085. doi: 10.1016/S0140-6736(11)60105-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986;73:1–11. [Google Scholar]
  • 22.Barlow WE. Robust variance estimation for the case-cohort design. Biometrics. 1994:1064–1072. [PubMed] [Google Scholar]
  • 23.Borgan O, Langholz B, Samuelsen SO, Goldstein L, Pogoda J. Exposure stratified case-cohort designs. Lifetime Data Anal. 2000;6:39–58. doi: 10.1023/a:1009661900674. [DOI] [PubMed] [Google Scholar]
  • 24.Horvitz DG, Thompson DJ. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc. 1952;47:663–685. [Google Scholar]
  • 25.Therneau TM, Li H. Computing the cox model for case cohort designs. Lifetime Data Anal. 1999;5:99–112. doi: 10.1023/a:1009691327335. [DOI] [PubMed] [Google Scholar]
  • 26.Langholz B, Jiao J. Computational methods for case-cohort studies. Comp Stat Data Anal. 2007;51:3737–3748. [Google Scholar]
  • 27.Pencina MJ, D’Agostino RBS, D’Agostino RBJ, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the roc curve to reclassification and beyond. Stat Med. 2008;27:157–72. doi: 10.1002/sim.2929. discussion 207–12. [DOI] [PubMed] [Google Scholar]
  • 28.Pepe MS, Kerr KF, Longton G, Wang Z. Testing for improvement in prediction model performance. Stat Med. 2013;32:1467–82. doi: 10.1002/sim.5727. Epub 2013 Jan 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Pencina MJ, D’Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11–21. doi: 10.1002/sim.4085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pencina MJ, D’Agostino RB, Pencina KM, Janssens ACJW, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol. 2012;176:473–81. doi: 10.1093/aje/kws207. Epub 2012 Aug 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Cook NR. Clinically relevant measures of fit? A note of caution. Am J Epidemiol. 2012;176:488–491. doi: 10.1093/aje/kws208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sanderson J, Thompson SG, White IR, Aspelund T, Pennells L. Derivation and assessment of risk prediction models using case-cohort data. BMC. 2013;13:1–11. doi: 10.1186/1471-2288-13-113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: The role of reclassification measures. Ann Intern Med. 2009;150:795–802. doi: 10.7326/0003-4819-150-11-200906020-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lee IM, Rexrode KM, Cook NR, Manson JE, Buring JE. Physical activity and coronary heart disease in women: Is “no pain, no gain” passé? JAMA. 2001;285:1447–1454. doi: 10.1001/jama.285.11.1447. [DOI] [PubMed] [Google Scholar]
  • 35.Sacco RL, Khatri M, Rundek T, Xu Q, Gardener H, Boden-Albala B, Di Tullio MR, Homma S, Elkind MS, Paik MC. Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic nomas (northern manhattan cohort study) J Am Coll Cardiol. 2009;54:2303–2311. doi: 10.1016/j.jacc.2009.07.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Arsenault BJ, Rana JS, Lemieux I, Després J-P, Wareham NJ, Kastelein JJP, Boekholdt SM, Khaw K-T. Physical activity, the framingham risk score and risk of coronary heart disease in men and women of the epic-norfolk study. Atherosclerosis. 2010;209:261–265. doi: 10.1016/j.atherosclerosis.2009.08.048. [DOI] [PubMed] [Google Scholar]
  • 37.Ingle L, Carroll S, Stamatakis E, Hamer M. Benefit of adding lifestyle-related risk factors for prediction of cardiovascular death among cardiac patients. Int J Cardiol. 2013;163:196–200. doi: 10.1016/j.ijcard.2011.06.001. [DOI] [PubMed] [Google Scholar]
  • 38.Faeh D, Braun J, Bopp M. Body mass index vs cholesterol in cardiovascular disease risk prediction models. Arch Intern Med. 2012:1–3. doi: 10.1001/2013.jamainternmed.327. [DOI] [PubMed] [Google Scholar]
  • 39.Gupta S, Rohatgi A, Ayers CR, Willis BL, Haskell WL, Khera A, Drazner MH, de Lemos JA, Berry JD. Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality. Circulation. 2011;123:1377–1383. doi: 10.1161/CIRCULATIONAHA.110.003236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Després J-P. Body fat distribution and risk of cardiovascular disease: An update. Circulation. 2012;126:1301–1313. doi: 10.1161/CIRCULATIONAHA.111.067264. [DOI] [PubMed] [Google Scholar]
  • 41.Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet. N Engl J Med. 2001;344:3–10. doi: 10.1056/NEJM200101043440101. [DOI] [PubMed] [Google Scholar]
  • 42.Duncan JJ, Gordon NF, Scott CB. Women walking for health and fitness. JAMA. 1991;266:3295–3299. [PubMed] [Google Scholar]
  • 43.Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374:1677. doi: 10.1016/S0140-6736(09)61457-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ford ES, Bergmann MM, Boeing H, Li C, Capewell S. Healthy lifestyle behaviors and all-cause mortality among adults in the united states. Prev Med. 2012;55:23–27. doi: 10.1016/j.ypmed.2012.04.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Eckel RH, Jakicic JM, Ard JD, Miller NH, Hubbard VS, Nonas CA, de Jesus JM, Sacks FM, Lee I-M, Smith SC. 2013 aha/acc guideline on lifestyle management to reduce cardiovascular riska report of the american college of cardiology/american heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2960–84. doi: 10.1016/j.jacc.2013.11.003. Epub 2013 Nov 12. [DOI] [PubMed] [Google Scholar]
  • 46.Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: A pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383:970–983. doi: 10.1016/S0140-6736(13)61836-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Collaboration ERF. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. The Lancet. 2011;377:1085–1095. doi: 10.1016/S0140-6736(11)60105-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Clinical Perspective
Supplemental Material

RESOURCES